fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New oral GLP-1RA orforglipron comparable to semaglutide for weight loss

Written by | 22 Apr 2025

Results from the ACHIEVE-1 trial show that treatment with orforglipron was associated with weight loss ranging from 4.7 – 7.9% (4.4 – 7.3 Kg) of body weight in… read more.

Study finds women much more likely to be aware of and have good understanding of obesity drugs

Written by | 21 Apr 2025

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that women are much more aware of knowledgeable about… read more.

Study suggests lean muscle mass loss can be minimized during weight loss therapy using newer incretin obesity drugs

Written by | 14 Apr 2025

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP… read more.

Expanding access to anti-obesity medications delivers 13% return on investment for society

Written by | 31 Mar 2025

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a substantial societal return… read more.

Most older adults say Medicare and other insurance should cover obesity drugs, and many show interest in using them

Written by | 30 Mar 2025

A large majority of older Americans feel that health insurance – including Medicare – should cover anti-obesity medications, according to a new University of Michigan study. And more… read more.

Obesity Action Coalition & The Obesity Society send letter to FDA on behalf of more than 20 leading organizations & providers urging enforcement of compounding regulations

Written by | 25 Mar 2025

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading… read more.

GLP-1 RAs – where are we now? What have we learned?

Written by | 17 Mar 2025

Pharmacist Deborah Evans runs a weight-management clinic at Remedi Health in Winchester. She has helped many people to lose weight and improve their health using the GLP-1 receptor… read more.

Taking semaglutide before bariatric surgery does not improve weight loss or safety

Written by | 15 Mar 2025

Mass General Brigham researchers found that total weight loss did not increase for patients who took semaglutide before having weight loss surgery, suggesting that a surgery first strategy… read more.

Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients

Written by | 5 Mar 2025

Eli Lilly and Company announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program… read more.

SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission

Written by | 9 Feb 2025

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher… read more.

Fizzy water might aid weight loss by boosting glucose uptake and metabolism

Written by | 31 Jan 2025

Fizzy water might aid weight loss by boosting blood glucose uptake and metabolism—the rate at which the body uses and converts energy—but the effects are so small, drinking… read more.

Calorie labelling leads to modest reductions in selection and consumption

Written by | 21 Jan 2025

A new Cochrane review has found that calorie labelling of food on menus and products leads people to choose slightly fewer calories. The research team, led by scientists… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.